NO984620L - Nye indanolforbindelser, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem - Google Patents
Nye indanolforbindelser, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende demInfo
- Publication number
- NO984620L NO984620L NO984620A NO984620A NO984620L NO 984620 L NO984620 L NO 984620L NO 984620 A NO984620 A NO 984620A NO 984620 A NO984620 A NO 984620A NO 984620 L NO984620 L NO 984620L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- alkoxy
- new
- atoms
- preparation
- Prior art date
Links
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical class C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- KAQJERBONUSJEE-UHFFFAOYSA-N 1-piperidin-1-yl-2,3-dihydroinden-1-ol Chemical class C1CC2=CC=CC=C2C1(O)N1CCCCC1 KAQJERBONUSJEE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9712336A FR2769312B1 (fr) | 1997-10-03 | 1997-10-03 | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO984620D0 NO984620D0 (no) | 1998-10-02 |
| NO984620L true NO984620L (no) | 1999-04-06 |
| NO316693B1 NO316693B1 (no) | 2004-03-26 |
Family
ID=9511782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19984620A NO316693B1 (no) | 1997-10-03 | 1998-10-02 | Nye indanolforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5958927A (no) |
| EP (1) | EP0906912B1 (no) |
| JP (1) | JP3884177B2 (no) |
| CN (1) | CN1122666C (no) |
| AT (1) | ATE230739T1 (no) |
| AU (1) | AU736710B2 (no) |
| BR (1) | BR9804485A (no) |
| CA (1) | CA2249756C (no) |
| DE (1) | DE69810560T2 (no) |
| DK (1) | DK0906912T3 (no) |
| ES (1) | ES2190574T3 (no) |
| FR (1) | FR2769312B1 (no) |
| HU (1) | HUP9802194A1 (no) |
| NO (1) | NO316693B1 (no) |
| NZ (1) | NZ332142A (no) |
| PL (1) | PL191091B1 (no) |
| PT (1) | PT906912E (no) |
| ZA (1) | ZA989011B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2002519323A (ja) * | 1998-06-30 | 2002-07-02 | イーライ・リリー・アンド・カンパニー | セロトニン関連系に効果を及ぼすピペリジン誘導体 |
| US6197798B1 (en) | 1998-07-21 | 2001-03-06 | Novartis Ag | Amino-benzocycloalkane derivatives |
| US6878707B2 (en) * | 2000-01-18 | 2005-04-12 | Novartis Ag | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| US20020077278A1 (en) * | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| DE10142661B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
| DE10142667B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
| DE10142662B4 (de) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
| FR2883876B1 (fr) * | 2005-03-30 | 2007-05-04 | Servier Lab | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0190472B1 (en) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | New pharmaceutical compositions having anti-psychotic properties |
| JPH01503777A (ja) * | 1985-10-04 | 1989-12-21 | マツジヨ‐ニ‐ウインスロツプ・ソチエタ・ペル・アチオニ | 縮合脂環式アミノアルコール類 |
| FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
| FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1997
- 1997-10-03 FR FR9712336A patent/FR2769312B1/fr not_active Expired - Fee Related
-
1998
- 1998-09-30 CN CN98120594A patent/CN1122666C/zh not_active Expired - Fee Related
- 1998-10-01 CA CA002249756A patent/CA2249756C/fr not_active Expired - Fee Related
- 1998-10-01 DK DK98402415T patent/DK0906912T3/da active
- 1998-10-01 AT AT98402415T patent/ATE230739T1/de not_active IP Right Cessation
- 1998-10-01 EP EP98402415A patent/EP0906912B1/fr not_active Expired - Lifetime
- 1998-10-01 DE DE69810560T patent/DE69810560T2/de not_active Expired - Fee Related
- 1998-10-01 PT PT98402415T patent/PT906912E/pt unknown
- 1998-10-01 ES ES98402415T patent/ES2190574T3/es not_active Expired - Lifetime
- 1998-10-02 JP JP28063998A patent/JP3884177B2/ja not_active Expired - Fee Related
- 1998-10-02 HU HU9802194A patent/HUP9802194A1/hu unknown
- 1998-10-02 US US09/165,844 patent/US5958927A/en not_active Expired - Fee Related
- 1998-10-02 NZ NZ332142A patent/NZ332142A/xx unknown
- 1998-10-02 AU AU87875/98A patent/AU736710B2/en not_active Ceased
- 1998-10-02 NO NO19984620A patent/NO316693B1/no unknown
- 1998-10-02 ZA ZA989011A patent/ZA989011B/xx unknown
- 1998-10-02 PL PL328989A patent/PL191091B1/pl not_active IP Right Cessation
- 1998-10-05 BR BR9804485-0A patent/BR9804485A/pt not_active Application Discontinuation
-
1999
- 1999-03-22 US US09/273,889 patent/US6060487A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT906912E (pt) | 2003-04-30 |
| CA2249756A1 (fr) | 1999-04-03 |
| DE69810560D1 (de) | 2003-02-13 |
| HK1019736A1 (en) | 2000-02-25 |
| PL328989A1 (en) | 1999-04-12 |
| US5958927A (en) | 1999-09-28 |
| HU9802194D0 (en) | 1998-11-30 |
| AU8787598A (en) | 1999-04-22 |
| DK0906912T3 (da) | 2003-04-22 |
| US6060487A (en) | 2000-05-09 |
| AU736710B2 (en) | 2001-08-02 |
| ATE230739T1 (de) | 2003-01-15 |
| NO984620D0 (no) | 1998-10-02 |
| FR2769312A1 (fr) | 1999-04-09 |
| CN1218051A (zh) | 1999-06-02 |
| NZ332142A (en) | 2000-05-26 |
| CA2249756C (fr) | 2003-12-02 |
| FR2769312B1 (fr) | 1999-12-03 |
| PL191091B1 (pl) | 2006-03-31 |
| EP0906912A1 (fr) | 1999-04-07 |
| ES2190574T3 (es) | 2003-08-01 |
| EP0906912B1 (fr) | 2003-01-08 |
| CN1122666C (zh) | 2003-10-01 |
| DE69810560T2 (de) | 2003-11-27 |
| HUP9802194A1 (hu) | 1999-12-28 |
| NO316693B1 (no) | 2004-03-26 |
| BR9804485A (pt) | 2000-04-11 |
| ZA989011B (en) | 1999-04-12 |
| JPH11158179A (ja) | 1999-06-15 |
| JP3884177B2 (ja) | 2007-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
| BR0317294A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários | |
| DE69208089D1 (de) | Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung | |
| FR2725206B1 (fr) | Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
| NO984620D0 (no) | Nye indanolforbindelser, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem | |
| DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| IL103595A0 (en) | 2-heterocyclicethylamine derivatives,their preparation and pharmaceutical compositions containing them | |
| HU895648D0 (en) | Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds | |
| DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
| IE830685L (en) | Piperidine derivatives. |